Showing results (191-200 of 207) with videos related to
Sort By:
Pageof 21
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2017
[Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy]E Blais, B Pichon, A Mampuya, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2004
[Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy]M Ychou, G Gory-Delabaere, P Blanc, et al.International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary resultsP Bey, C Carrie, V Beckendorf, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 30, 2020
Dose distribution of the brain tissue associated with cognitive functions in high-grade glioma patientsJ Jacob, E Clausse, M A Benadjaoud, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 18, 2003
[Target-volume and critical-organ delineation for conformal radiotherapy of prostate cancer: experience of French dose-escalation trials]V Beckendorf, J M Bachaud, P Bey, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2012
[Role of French teams in the development of clinical and translational research in radiation oncology]D Azria, J-M Ardiet, B Chauvet, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 19, 2018
[Quality and safety policy implementation for a new radiotherapy device]C Martin, R Jumeau, E Blais, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 27, 2021
A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patientsN Khalladi, C Dejean, M Bosset, et al.Ebiomedicine|March 5, 2019
RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort studyC Mirjolet, J L Merlin, G Truc, et al.Critical Reviews in Oncology/Hematology|May 16, 2009
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 casesB Cutuli, C Cohen-Solal Le-Nir, D Serin, et al.Pageof 21